Measuring Public Preferences for Health Outcomes and Expenditures in a Context of Healthcare Resource Re-Allocation.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2019 AND VI 37 AND IP 3
Results: 9
1
2
Cost Effectiveness of Inhaled Mannitol (Bronchitol<sup>®</sup>) in Patients with Cystic Fibrosis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
3
Evaluating Cost-Effectiveness Models for Pharmacologic Interventions in Adults with Heart Failure: A Systematic Literature Review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
4
Cladribine Tablets for the First-Line Treatment of Relapsing-Remitting Multiple Sclerosis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article
5
Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review.
- Published in:
- 2019
- By:
- Publication type:
- journal article
6
Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States.
- Published in:
- 2019
- By:
- Publication type:
- journal article
7
Determining Value in Health Technology Assessment: Stay the Course or Tack Away?
- Published in:
- 2019
- By:
- Publication type:
- journal article
8
Opioid Use is Associated with Higher Severity-Adjusted Episode Costs in Patients with Conservatively Managed Degenerative Joint Disease of the Back and Neck.
- Published in:
- 2019
- By:
- Publication type:
- journal article
9
Ibrutinib for Treating Relapsed or Refractory Mantle Cell Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
- Published in:
- 2019
- By:
- Publication type:
- journal article